INVO Reports Fourth Quarter and Full Year 2023 Financial Results

April 16, 2024

https://www.globenewswire.com/news-release/2024/04/16/2864137/0/en/INVO-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html

SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) — INVO Bioscience, Inc. (Nasdaq:INVO) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and with the intravaginal culture (“IVC”) procedure enabled by its INVOcell® medical device, today announced financial results for the fourth quarter and fiscal year ended December 31, 2023 and provided a business update.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.